The Carvedilol District Court Case: More May Be Needed to Prove Inducement from a Generic …

In an opinion dated March 28, 2018 (GlaxoSmithKline v. Teva, No. 14-878-LPS-CJB (D. Del.)), Judge Stark of the District of Delaware granted Teva’s motion for judgment as a matter of law (“JMOL”) holding that GSK failed to present sufficient evidence that Teva induced infringement of GSK’s U.S. patent …